Latest news
Loading news…
Vertex Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Boston, Massachusetts, United States Founded 1989 5001-10000 employees For Profit
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
9
Investments
7
2 exits
Monthly Visits
Available in Pro Contacts
5,257
Ticker
VRTX
NASDAQ
Patents
1,099
188 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- VRTX
- Exchange
- NASDAQ
- IPO date
- Jul 25, 1991
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 73
- Mobile apps
- 9
- Downloads (30d)
- 124
- Active products
- 27
- Patents granted
- 1,099
- Trademarks
- 188
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $260M
Investor Activity
- Investments
- 7
- Lead investments
- 2
- Portfolio orgs
- 5
- Diversity investments
- 1
- Exits
- 2
- Exits via IPO
- 2
Company Info
- Founded
- 1989
- Employees
- 5001-10000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 3
- Sub-organizations
- 1
- News articles
- 1,739
- Events
- 2
- HQ
- Boston, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Jul 25, 1991
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 0.6
- Trend (30d)
- 9
- Trend (90d)
- 8.8
- Last leadership hire
- Feb 1, 2026
- Last layoff mention
- Feb 5, 2026
Investments by Vertex Pharmaceuticals
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Vertex Pharmaceuticals
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Vertex Pharmaceuticals
J
Executive Chairman
R
President and Chief Executive Officer
J
Senior Vice President, Genetic Therapies Research
D
Executive Vice President, Global Research and Chief Scientific Officer
N
Senior Vice President and Chief Communications Officer
B
Executive Vice President, Chief of Cell and Genetic Therapies and VCGT Site Head
F
Disease Area Executive, Type 1 diabetes
M
Chairman of the Board of Director
B
Principal Scientist, Translational Engineering
G
Senior Director
L
Senior Vice President, International Commercial Operations
W
Producer
S
Sr.Director Quality Analytics
D
Research Scholar
M
Associate Director, Validation for Continuous Manufacturing and Automation
G
Sr Director, Global Digital Marketing
J
Chief Legal Officer
S
Senior Vice President & Chief Human Resources Officer
B
VP Research Technology
F
Director Computational Drug Design
D
Vice President, Talent and Inclusion, Diversity & Equity
A
Executive Vice President, Chief Patient Officer. and Chief of Staff
K
Executive Director, Head of Corporate Responsibility
A
Senior Principal Data Scientist
5,257
professional contacts at Vertex Pharmaceuticals
Contact execs at Vertex Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Vertex Pharmaceuticals
Loading news…
FAQs about Vertex Pharmaceuticals
People who checked this page also checked these
Sectors Vertex Pharmaceuticals invests & acquires in
Browse the full Acquirezy directory.